MEDICAL DEVELOPMENTS ORDINARY (MVP) News
Latest articles and price-sensitive announcements with AI sentiment classification.
ASX
Google NewsMedical Developments (ASX:MVP) Surges 35% After Penthrox Drives Positive Cash Flow and European Expansion - Stocks Down Under
Medical Developments (ASX:MVP) Surges 35% After Penthrox Drives Positive Cash Flow and European Expansion Stocks Down Under
KalkineWhy Is (ASX:MVP) Gaining Attention as Penthrox Strengthens Cash Flow?
Highlights Strong demand lifts flagship pain product Cash flow turns positive amid steady expansion Europe remains a key focus for upcoming approvals Medical Developments International is witnessing stronger commercial traction, supported by its flagship product and improving financial stability, while regulatory progress in Europe continues to shape its near-term outlook. A Turning Point for Medical Developments International Medical Developments International (ASX:MVP) has delivered a...
Appendix 4C and Quarterly Activity Report 31 March 2026
other announcement
StockheadHealth Check: US report ponders the dark side of dollar-driven medical AI
AI is pitched as a way to improve and expedite patient treatment and create clinical efficiencies. But is it really ... Read More The post Health Check: US report ponders the dark side of dollar-driven medical AI appeared first on Stockhead.
Appendix 4C and Quarterly Activity Report 31 December 2025
other announcement
Change of Director's Interest Notice - R Basser
director_dealing announcement
2025 Annual General Meeting Chair and CEO addresses
other announcement
Appendix 4C and Quarterly Activity Report 30 September2025
other announcement
Change of Director's Interest Notice - M Fladrich
director_dealing announcement
Change of Director's Interest Notice - P Townsend
director_dealing announcement
Date of AGM and Closing Date for Director Nominations
other announcement
Appendix 4C and Quarterly Activity Report - 30 June 2025
other announcement
Appendix 4C and Quarterly Activity Report - 31 March 2025
other announcement
Appendix 4C and Quarterly Activity Report -31 December 2024
other announcement
MVP Investor Presentation - Bell Potter Conference
other announcement
Appendix 4C & Quarterly Activity Report - 30 September 2024
other announcement
Date of AGM and Closing Date for Director Nominations
other announcement